Pathology and pathogenesis of bioterrorism-related inhalational anthrax

American Journal of Pathology

Volumn 163, Issue 2, 2003, Pages 701-709

  Guarner, Jeannette ^a   Jernigan, John A ^b   Shieh, Wun Ju ^a   Tatti, Kathleen ^a   Flannagan, Lisa M ^d   Stephens, David S ^c   Popovic, Tanja ^c   Ashford, David A ^c   Perkins, Bradley A ^c   Zaki, Sherif R ^a,e  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Research and Evaluation Branch   (United States)

^c NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^d Medical Examiner Office   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY;

ADULT; AGED; ANTHRAX; ARTICLE; BACILLUS ANTHRACIS; BIOLOGICAL WARFARE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; GRAM STAINING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYALINE MEMBRANE DISEASE; IMMUNOHISTOCHEMISTRY; LUNG INFILTRATE; MALE; MEDIASTINITIS; PATHOGENESIS; PATHOLOGY; PLEURA EFFUSION; PRIORITY JOURNAL; THORAX RADIOGRAPHY;

EID: 0042845996     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63697-8     Document Type: Article

References (29)

1. CDC Update: investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001. MMWR Morb Mortal Wkly Rep 2001, 50:889-893
2. CDC Update: investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. MMWR Morb Mortal Wkly Rep 2001, 50:909-919
3. CDC Update: investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax. MMWR Morb Mortal Wkly Rep 2001, 50:941-948
4. CDC Update: investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis. MMWR Morb Mortal Wkly Rep 2001, 50:973-976
5. CDC Update: Investigation of bioterrorism-related inhalational anthrax, Connecticut, 2001. MMWR Morb Mortal Wkly Rep 2001, 50:1029-1031
6. Jernigan JA, Stephens DS, Ashford DA, Omenaca C, Topiel MS, Galbraith M, Tapper M, Fisk TL, Zaki S, Popovic T, Meyer RF, Quinn CP, Harper SA, Fridkin SK, Sejvar JJ, Shepard CW, McConnell J, Guarner J, Shieh WJ, Malecki JM, Gerberding JL, Hughes JM, Perkins BA, and members of the anthrax bioterrorism investigation team: Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis 2001, 7:933-944
7. Grinberg LM, Abramova FA, Yampolskaya OV, Walker DH, Smith JH: Quantitative pathology of inhalational anthrax 1: quantitative microscopic findings. Mod Pathol 2001, 14:482-495
8. Walker DH, Yampolska O, Grinberg LM: Death at Sverdlovsk: what have we learned? Am J Pathol 1994, 144:1135-1141
9. Abramova FA, Grinberg LM, Yampolskaya OV, Walker DH: Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979. Proc Natl Acad Sci USA 1993, 90:2291-2294
10. Albrink WS, Brooks SM, Biron RE, Kopel M: Human inhalation anthrax, a report of three fatal cases. Am J Pathol 1960, 61:457-471
11. Enticknap JB, Galbraith NS, Tomlinson JH, Elias-Jones TF: Pulmonary anthrax caused by contaminated sacks. Br J Industr Med 1968, 25:72-74
12. Severn M: A fatal case of pulmonary anthrax. Br Med J 1976, 1:748
13. Bush LM, Abrams BH, Beall A, Johnson CC: Index case of fatal inhalational anthrax due to bioterrorism in the United States. N Engl J Med 2001, 345:1607-1610
14. Borio L, Frank D, Mani V, Chiriboga C, Pollanen M, Ripple M, Ali S, DiAngelo C, Lee J, Arden J, Titus J, Fowler D, O'Toole T, Masur H, Bartlett J, Inglesby T: Death due to bioterrorism-related inhalational anthrax. JAMA 2001, 286:2554-2559
15. Quintiliani R Jr, Quintiliani R: Fatal case of inhalational anthrax mimicking intra-abdominal sepsis. Conn Med 2002, 66:261-267
16. Barakat LA, Quentzel HL, Jernigan JA, Kirschke DL, Griffith K, Spear SM, Kelley K, Barden D, Mayo D, Stephens DS, Popovic T, Martson C, Zaki SR, Guarner J, Shieh WJ, Carver HW, Meyer RF, Swerdlow DL, Mast EE, Hadler JL, for the Anthrax Bioterrorism Investigation Team: Fatal inhalational anthrax in a 94-year-old Connecticut woman. JAMA 2002, 287:863-868
17. Jernigan DB, Raghunathan PL, Bell BP, Brechner R, Bresnitz EA, Butler JC, Cetron M, Cohen M, Doyle T, Fischer M, Green C, Griffith KS, Guarner J, Hadler JL, Hayslett JA, Meyer R, Petersen LR, Phillips M, Pinner R, Popovic T, Quinn CP, Reefhuis J, Reissman D, Rosenstein N, Schuchat A, Shieh WJ, Siegal L, Swerdlow DL, Tenover FC, Traeger M, Ward JW, Weisfuse I, Wiersma S, Yeskey K, Zaki S, Ashford DA, Perkins BA, Ostroff S, Hughes J, Fleming D, Koplan JP, Gerberding JL, and the National Anthrax Epidemiologic Investigation Team: Investigation of bioterrorism-related anthrax, United States 2001: epidemiologic findings. Emerg Infect Dis 2002, 8:1019-28
18. Ezzell JW, Abshire TG, Little SF, Lidgerding BC, Brown C: Identification of Bacillus anthracis by using monoclonal antibody to cell wall galactose-N-acetylglucosamine polysaccharide. J Clin Microbiol 1990, 28:223-231
19. De BK, Bragg SL, Sanden GN, Wilson KE, Diem LA, Marston CK, Hoffmaster AR, Barnett GA, Weyant RS, Abshire TG, Ezzell JW, Popovic T: Two-component direct fluorescent-antibody assay for rapid identification of Bacillus anthracis. Emerg Infect Dis 2002, 8:1060-1065
20. Hoffmaster AR, Meyer RF, Bowen MP, Marston CK, Weyant RS, Barnett GA, Sejvar JJ: Jernigan JA, Perkins BA, Popovic T: Evaluation and validation of real-time polymerase chain reaction assay for rapid identification of Bacillus anthracis. Emerg Infect Dis 2002, 8:1178-1181
21. Ross JM: The pathogenesis of anthrax following the administration of spores by the respiratory route. J Pathol Bact 1957, 73:485-494
22. Barnes JM: The development of anthrax following the administration of spores by inhalation. Br J Exp Pathol 1947, 28:385-394
23. Hanna PC, Acosta D, Collier RJ: On the role of macrophages in anthrax. Proc Natl Acad Sci USA 1993; 90:10198-10201
24. Dixon TC, Meselson M, Guillemini J, Hanna PC: Anthrax. N Engl J Med 1999, 341:815-826
25. Fritz DL, Jaax NK: Lawrence WB, Davis KJ, Pitt MLM, Ezzell JW, Friedlander AM: Pathology of experimental inhalation anthrax in the Rhesus monkey. Lab Invest 1995, 73:691-702
26. CDC: Biological and chemical terrorism: strategic plan for preparedness and response: recommendations of the CDC strategic planning workgroup. MMWR Morb Mortal Wkly Rep 2000, 49:1-14
27. Guarner J, Greer PW, Bartlett J, Chu MC, Shieh WJ, Zaki SR: Immunohistochemical detection of Francisella tularensis in formalin-fixed paraffin-embedded tissue. App Immunohisto Molec Morphol 1999, 7:122-126
28. Guarner J, Shieh WJ, Greer PW, Gabastou JM, Chu M, Hayes E, Nolte KB, Zaki SR: Immunohistochemical detection of Yersinia pestis in formalin-fixed, paraffin-embedded tissue. Am J Clin Pathol 2002, 117:205-209
29. Zaki SR, Shieh WJ, Greer PW, Goldsmith CS, Ferebee T, Katshitshi J, Tshioko FK, Bwaka MA, Swanepoel R, Calain P, Khan AS, Lloyd E, Rollin PE, Ksiazek TG, Peters CJ: A novel immunohistochemical assay for the detection of ebola virus in skin: implications for diagnosis, spread, and surveillance of ebola hemorrhagic fever. J Infect Dis 1999, 179(Suppl 1):S36-S47